Lenacapavir PrEP roll-out begins in Africa

The Lancet HIV 2026

View at publisher

Authors: Paul Adepoju

DOI: 10.1016/s2352-3018(26)00103-7

Cited by: 1

Fields of Study & Subjects

Biotechnology and Related Fields HIV/AIDS drug development and treatment Trypanosoma species research and implications